Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fingolimod-associated amenorrhea: a report of three cases.
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation.
Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.
Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-Beta.
Sildenafil (Viagra®) down regulates cytokines and prevents demyelination in a cuprizone-induced MS mouse model.
Yield of training exchanges between Europe and Sub-Saharan Africa.
Low serum urate levels are associated to female gender in multiple sclerosis patients.
A Multiple Sclerosis-Associated Variant of CBLB Links Genetic Risk with Type I IFN Function.
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.
Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis.
A TSPO ligand is protective in a mouse model of multiple sclerosis.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis.
Persons with multiple sclerosis show altered joint kinetics during walking after participating in elliptical exercise.
Correction: Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis.
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.
Retinal nerve fibre layer and brain grey substance as early prognostic factors for disability in multiple sclerosis.
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.
Body composition in multiple sclerosis.
Flavonoid-Based Therapies in the Early Management of Neurodegenerative Diseases.
Pages
« first
‹ previous
…
284
285
286
287
288
289
290
291
292
…
next ›
last »